Independent Review Committee

in page functions

Gavi has established an Independent Review Committee for the review of new proposals

To support an independent and systematic process of reviewing new proposals, Gavi has established an Independent Review Committee (IRC).

Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics;
  • the committee is based on a system of peer review; and
  • the committee is independent.

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.


Round 1  

Round 2  

Round 3  

Submission cut-off dates

22 January 2019

1 May 2019

4 September 2019

Review dates (indicative)

11-22 March 2019

1–12 July 2019

28 Oct - 8 Nov 2019

The Independent Review Committee reviews new proposals and makes recommendations to the Gavi Board

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’;
  • the Gavi's strategic goals; and
  • the eligibility criteria as per Gavi guidelines for new proposals of support.

Members of the Independent Review Committee consist of specialists from a broad range of expertise

IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

Click here to view Terms of Reference for the Gavi Independent Review Committee  

Range of expertise

The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

  • Routine immunisation programmes, especially at country level;
  • Management of campaigns;
  • Delivery of health services including child and adolescent health;
  • Health systems strengthening and management;
  • Epidemiology and disease control;
  • Cold chain and logistics;
  • Financial and budget analysis; and
  • Gender and equity.

The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

List of IRC pool members

Click here to view the biographies of the IRC members  



Areas of expertise  


Emmanuel Addo-Yobo

Child health; clinical paediatrics; surveillance for rotavirus and congenital rubella syndrome


Salah Al Awaidy

Vaccine-preventable diseases programming, epidemiology, public health, immunisation, M&E, AEFI, Measles, Rubella, MR campaign, MenA, Rota and HPV


Rafah Salam Aziz

MNCH programme management, immunisation


Alejo Bejemino

Cold chain/Supply chain and logistics Management


Annette Bongiovanni

Programme management, monitoring and evaluation, and operations research


Brent Burkholder

Epidemiology, vaccine programmes and disease control, outbreak investigations


Diego Buriot

Public health interventions, communicable diseases, fragile and crisis settings


Pierre Bwale

Health care delivery, campaigns, emergencies, programmes for hard-to-reach communities


Lisa Cairns

Immunisation policy, epidemiology, M&R control, national immunisation programme reviews


Aleksandra Caric

Immunisation, vaccine safety and regulation, programme management and administration


Gabriel Carrasquilla

Epidemiology, immunisation programmes


Amos Chweya

Public health logistics, procurement and logistics management of immunisation activities


Sadia Chowdhury

Reproductive Health, HSS, child health services, programme delivery, M&E of health programmes


John Clements

Routine immunisation services in developing countries


Natasha Crowcroft

Epidemiology, HSS, HPV, measles, outbreak control, training and capacity building


Dora Curry

CSOs, data systems at community and primary care level, data utilization for programme improvement


Celestino Costa

Cold chain, immunisation, HSS, emergency responses, primary health care


John Crump

Infectious diseases, epidemiology, outbreak responses, typhoid


Henrique D’Alva

Cold chain, EPI logistics


Kevin De Cock

Global public health, HIV, emergency & outbreak response, HSS


Modibo Dicko

Supply chain management, introducing innovative technologies, management systems and practices in health supply systems


Abdoulaye Oumar Djigo

Management, logistics in health sector, engineering (cold chain, biomedical equipment, energy efficiency, environment)


Linda Eckert

Vaccines, especially in the intersection of immunisation with reproductive health


Marta Feletto

Gender equality, M&E, immunisation programme, HPV


Djordie Gikic

HSS, proposal development, immunisation systems evaluation, service delivery, health policies


Melita Gordon

Gastroenterology, disease surveillance, typhoid, vaccine trials


John Grundy

Health policy, campaign delivery, HSS, programme evaluation


Terence Hart

Immunisation supply chain and logistics, environmental sustainability and corporate management


Bradley Hersh

Health policy, immunisation, outbreaks, campaigns, measles control


Natasha Howard

Health policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background


Hector Izurieta

Immunisation campaign management, public health, measles control, epidemiology, policy making


Philippe Jaillard

Vaccine delivery, cold chain equipment management, injection safety and waste management, logistics training program development


Miloud Kaddar

Health economics, economics of vaccines and immunisation, health system development and financing


Kabelwa Kagaruki

General public health, immunisation logistics/supply chain, EPI monitoring and evaluation


Clifford Kamara

Health development, immunisation services, recovery programme, management and evaluation of health programmes


Jean Rostand Kamga

Financial & budget analysis, management and governance, audits, financial investigations


Toagoe Karzon

Project funding, financial reporting and budget control, conducting audits


Tcha Landry Kaucley

Cold Chain, vaccine logistics, EPI monitoring & evaluation, public health management


Wassim Khrouf

Financial & budget analysis, audits, project assessment


Vladimir Lazarevik

Healthcare system transformation, health financing design, health policy development


Stefano Lazzari

Outbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management


Dafrossa Lyimo

Immunisation campaign management, public health, health systems management, health policies, disease control


Kapil Maithal

Conceptualizing, managing, strategizing and execution of development of vaccines for global use, vaccine advocacy and preparedness


Marty Makinen

Health economics, immunisation


Osman Mansoor

Immunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics


Viviana Mangiaterra

Child health, epidemiology, HSS, immunisation programmes


Claude Mangobo

Management of cold chain equipment and vaccine management, maintenance and installation of solar cold chain equipment


Florian Marks

Public health, vaccinology and policy making, outbreak responses, campaign evaluations


Tawanda Marufu

Fragile settings, HSS, epidemiology, health policy, HPV, Typhoid, measles


Mark Miller

Epidemiology, vaccine research, public health, outbreak investigations, disease control


Sandra Mounier-Jack

Immunisation programmes, health systems strengthening, HPV vaccine, measles elimination, health policy and health financing


Kondwani Msampha

Financial & budget analysis, HSS, global health and integrated service delivery


Amani Mustafa

Immunisation, new vaccines, campaign management, cold chain and health system planning and monitoring


Maryanne Neill

Health information systems, cold chain logistics, immunisation coverage estimation.


Benjamin Nkowane

Vaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health


Peter Nsubuga

Epidemiology, measles control, cold chain, HSS


Frank Nyonator

Health systems and health service provision


Jean Marc Olive

Immunisation programmes, emergency strategies & disaster relief, measles elimination


Adepeju Olukoya

Gender, women and health, sexual and reproductive health, health systems


Virgil Onama

Project design, M&E, results-based management, health financing & policy, fragile settings


Bolanle Oyeledun

HSS, MNCH, immunisation, adolescent reproductive health & HPV, programme assessments and evaluations


Koyejo Oyerinde

Paediatrics, health systems strengthening


Michael Park

Programme management and evaluation, primary care, health systems and public health


Zeenat Patel

Epidemiology, communicable disease control/outbreak preparedness, sexual & reproductive health, NVS Introduction, campaigns, IMNCI/iCCM (pneumonia, diarrhoea and malaria programming)


Ian Pett

Health care, cold chain, HSS, outbreak response, emergencies


Arletty Pinel

Health systems strengthening, maternal health


Robert (Bob) Pond

Health systems strengthening, data quality assessment, epidemiology


Kshem Prasad

Evaluation of programme logistics, assessments of immunisation supply chain and development of plans for system strengthening


Arthur Reingold

Epidemiology, measles control, vaccination delivery, strengthening health infrastructure


Diana Rivington

Gender equality, human rights, children’s rights


Cheikh Mohamed Hafis Seck

Financial & budget analysis, financial management of donor-funded programs, audit, grant agreements


Craig Shapiro

Management of immunisation programmes, policy development, public health, cold chain evaluation, HSS activities


Mario Stassen

Design of development strategies, risk based management and patient safety, immunisation supply chain logistics (cold chain), CMC (Bio) Pharmaceuticals


Simon (Sam) Sternin

Global health generalist, HSS, disaster management, coverage and equity, CSOs


Ousmane Amadou Sy

Health and community systems strengthening, grant management support, financial management, organizational development


Michael Thiede

Health economics, health policy and health systems, procurement and logistics


Abdelmajid Tibouti

Financial & budget analysis, health economics, health financing strategies, monitoring and evaluation


Asnakew Tsega

Public health, epidemiology, programme management, monitoring and evaluation


Vivien Tsu

Epidemiology, new public health interventions, women's reproductive health, HPV, JE


Beena Varghese

Costing and evaluation of MNCH interventions, analysis of health system level issues in MNCH


Abdul G. Wali

Policy and strategy development, health information management, assessments, HSS, immunisation


Margaret Watkins

Immunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations


Karen Wilkins

Immunisation campaign management, proposals development, monitoring and evaluation, DQ assessments


Charles Shey Umaru Wiysonge

Vaccinology, systematic reviews, programme management


Aregai Woldegebriel

Epidemiology, SIA, MNCH, outbreaks, monitoring and evaluation


Shamsa Zafar

MNCH, Gender

Country portal

Applying for or receiving Gavi support? Visit our country portal.  

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here